BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 3, 2015
View Archived Issues
First-in-human results presented for LY-3023414
Read More
CD-133-targeted oncolytic adenovirus therapy shows promising preclinical results
Read More
Grant supports Adenovir's development of second-generation drug for epidemic keratoconjunctivitis
Read More
Medical Developments agrees to term sheet for European distribution of Penthrox
Read More
Bavarian Nordic confirms option exercise by U.S. Government for Filovirus vaccine
Read More
Almirall returns Kappaproct rights to InDex
Read More
New ultra-long-acting insulin analogue with improved PK/PD profile
Read More
Threshold Pharmaceuticals begins phase II study of TH-4000 in NSCLC
Read More
Novartis reports phase I results for INC-280 plus erlotinib
Read More
Nuclea Biotechnologies partners with Aelan Cell Technologies in epigenetics field
Read More
CytRx's new LADR technology platform expected to expand oncology pipeline
Read More
The Dana-Farber Cancer Institute discloses kinase inhibitors
Read More
First-in-human clear images of glioblastoma patients using [18F]AA-7
Read More
Roche provides initial update from phase IIb trial of sembragiline in Alzheimer's disease
Read More
Clovis Oncology begins rolling NDA submission for rociletinib
Read More
ALS groups fund two phase II studies focused on biomarkers
Read More
Preclinical and first-in-human data of BI-655064 as a CD40 inhibitor
Read More
Spiolto Respimat approved in first European countries for COPD
Read More
Yervoy receives approval for unresectable malignant melanoma in Japan
Read More
University of Tsukuba patent describes orexin OX2 receptor agonists
Read More
Roche and Chugai present BTK inhibitors
Read More
P2X4 negative modulators for pain in early development at Sunovion
Read More
Ajinomoto divulges AJS-1669 for type 2 diabetes
Read More
FDA approves Tuxarin ER
Read More
FDA grants approval to Orkambi for cystic fibrosis
Read More
Lilly's GLP-1 receptor agonist Trulicity Ateos approved in Japan
Read More
Boehringer Ingelheim's Ofev receives approval for IPF in Japan
Read More
Harvoni approved in Japan for genotype 1 HCV
Read More
